News for Omeros Corporation (OMER)

Omeros Corporation (Nasdaq: OMER) today announced the establishment of the Omeros Oncology Clinical Steering Committee to advance Omeros' OncotoX biologics pro

Omeros Corporation (NASDAQ:OMER) Q4 2024 Earnings Conference Call March 31, 2025 4:30 PM ETCompany ParticipantsJennifer Williams - Investor and Media...

Omeros Corporation OMER will release its fourth-quarter financial results after the closing bell on Monday, March 31. Analysts expect the Seattle, Washington-b...

Omeros Corporation (Nasdaq: OMER) today reported that clinical trial site activation for enrollment is underway for the company's Phase 3 program evaluating za

U.S. stock futures were lower this morning, with the Dow futures falling around 100 points on Monday. Shares of Incyte Corporation INCY fell sharply in today's...

Shares of Precision BioSciences, Inc. DTIL rose sharply in today's pre-market trading. Precision BioSciences reported clearance of investigational new drug app...

Omeros Corporation (Nasdaq: OMER) today announced that it has received a funding commitment from the National Institute on Drug Abuse (NIDA) for the upcoming y

Omeros Corporation's stock surges as narsoplimab data shows 68% lower death risk in HSCT-TMA patients. Click to learn about the potential and risks of OMER stock.

Omeros Corporation (Nasdaq: OMER) today announced the availability on its website of materials accompanying two presentations given at the 2025 Tandem Meetings

**media[536557]**

Omeros Corporation (Nasdaq: OMER) today announced statistical sensitivity analysis results related to the primary endpoint analysis for narsoplimab, Omeros' fi

Narsoplimab shows promise in reducing mortality for TA-TMA patients

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please ...

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 100 points on Thursday. The Dow traded up 0.55% to 42,557.62 whil...

U.S. stocks traded higher midway through trading, with the S&P 500 gaining around 0.4% on Thursday. The Dow traded up 0.39% to 42,493.51 while the NASDAQ rose ...

U.S. stocks were higher, with the Dow Jones index gaining over 150 points on Thursday. Shares of Accenture plc ACN rose sharply in today's session after the co...

Omeros stock surges on positive survival data for narsoplimab

Omeros Corporation's (OMER) stock surged 55% after positive trial results for narsoplimab, a potential treatment for stem cell transplant complications. Read more here.

Omeros' stock is volatile, driven by the potential FDA approval of narsoplimab for HSCT-TMA, despite past setbacks including an FDA rejection in 2021. Read more here.